Singapore, Singapore

Irma Silva Zolezzi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 4 EPO patents. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irma Silva Zolezzi. Retrieved from https://idiyas.com/inventor/irma-silva-zolezzi-vtmkwemh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Irma Silva Zolezzi - Innovator in Insulin Sensitizers

Introduction

Irma Silva Zolezzi is an inventor based in Singapore, SG. He is currently associated with the company Société des Produits Nestlé S.A. Although he does not hold any granted patents, his work in the field of insulin sensitizers is noteworthy.

Latest Patent Applications

Irma Silva Zolezzi has filed several patent applications, including:

1. **Scyllo-Inositol and Its Use as Insulin Sensitizer** - This invention relates to scyllo-inositol for use as an insulin sensitizer in the treatment or prevention of hyperglycemia. It further addresses disorders, conditions, and symptoms associated with hyperglycemia in a subject.

2. **Composition Comprising Isomers of Inositol and Its Use** - This application describes a combination of scyllo-inositol and myo-inositol as nutritional ingredients for the prevention or treatment of conditions such as prediabetes, type II diabetes, and gestational diabetes mellitus.

Conclusion

Irma Silva Zolezzi is making significant contributions to the field of insulin sensitizers through his innovative patent applications. His work has the potential to impact the treatment and prevention of diabetes-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…